Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-03

Clinical Trial Update: Bioavailability of Nasal Naloxone and Injected Naloxone Compared [Phase 1]

View source ↗

Summary

A Phase 1 trial completed comparing the bioavailability of nasal naloxone versus injectable naloxone for opioid overdose treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone injection (naloxone)
  • Naloxone nasal spray (naloxone nasal spray)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Drug Overdose | Phase 1 | Status: COMPLETED